Skip to main content

$0.056 -0.002 (-3.45%)

High

$0.06

Low

$0.06

Trades

69

Turnover

$115,211

Volume

1,984,515
30 June 2023 at 3:59pm
Register to track PYC and receive email alerts.
Subject
PYC Ann: Change of Director's Interest Notice

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Share Trading Policy

PYC Ann: Corporate Presentation - May 2022

PYC Ann: PYC Q2 Investor Call - 31 May 2022

PYC Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS

PYC Ann: Appendix A Terms and Conditions of Options

PYC Ann: Notification regarding unquoted securities - PYC

PYC Ann: Issue of Options

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Completes FDA Pre-IND engagement - RP11 program

PYC Ann: Q1 Investor Call Presentation

PYC Ann: Quarterly Investor Call March 2022

PYC Ann: Notification regarding unquoted securities - PYC

PYC Ann: Half Yearly Report and Accounts

PYC Ann: PYC Increases Shareholding in Vision Pharma

PYC Ann: Becoming a substantial holder

PYC Ann: Quarterly Activities and Appendix 4C Cash Flow Report

PYC Ann: Notification of cessation of securities - PYC

PYC Ann: Change in substantial holding

PYC Ann: Change of Registry Address

PYC Ann: Notification of cessation of securities - PYC

PYC Ann: Appendix C US Sub Plan

PYC Ann: Appendix B Terms and Conditions of Options

PYC Ann: Appendix A Terms and Conditions of Options

PYC Ann: Notification regarding unquoted securities - PYC

PYC Ann: Notification of cessation of securities - PYC

PYC Ann: Final Director's Interest Notice

PYC Ann: Results of 2021 Annual General Meeting

PYC Ann: 2021 AGM Chairman's Address and CEO Presentation

PYC Ann: Annual General Meeting - Conference Link

PYC Ann: Successful Completion of Key Translational Milestone

PYC Ann: Trading Halt

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Notice of Annual General Meeting/Proxy Form

PYC Ann: Retina Target Engagement Confirmed in Large Eye

PYC Ann: Corporate Governance Statement and Appendix 4G

PYC Ann: Annual Report to shareholders

PYC Ann: Upcoming Poster Presentations at TIDES USA and OTS 2021

PYC Ann: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

PYC Ann: Preliminary Final Report

PYC Ann: August Investor Update

PYC Ann: Ophthalmology-Focused Clinical Advisory Board

PYC Ann: PYC Quarterly Investor Call - August 17

PYC Ann: Participation in Upcoming U.S. Investor Conferences

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Commencement of Larger Animal Studies for Lead Program

PYC Ann: Change of Auditor

PYC Ann: VP-002 Program - Technical Presentation

PYC Ann: Exercise of Options

Register to track PYC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
RAC
TLX